Potential protective effects of Clostridium butyricum on experimental gastric ulcers in mice

World Journal of Gastroenterology

Volumn 21, Issue 27, 2015, Pages 8340-8351

  Wang, Fang Yan ^a,b,c,d   Liu, Jia Ming ^d   Luo, Hai Hua ^a,b,c   Liu, Ai Hua ^a,b,c   Jiang, Yong ^a,b,c  

^a FIRST MILITARY MEDICAL UNIVERSITY   (China)

^b BEIJING UNIVERSITY OF POSTS AND TELECOMMUNICATIONS   (China)

^c SOUTHERN MEDICAL UNIVERSITY   (China)

^d WENZHOU MEDICAL UNIVERSITY   (China)

Author keywords

Clostridium butyricum; Gastric ulcer; Inflammation; Oxidative stress; Probiotics

Indexed keywords

6 OXOPROSTAGLANDIN F1 ALPHA; ALCOHOL; ANTIULCER AGENT; CATALASE; INTERLEUKIN 1BETA; LEUKOTRIENE B4; MALONALDEHYDE; OMEPRAZOLE; PROBIOTIC AGENT; SUPEROXIDE DISMUTASE; TUMOR NECROSIS FACTOR ALPHA; AUTACOID; IL1B PROTEIN, MOUSE; PROTON PUMP INHIBITOR; TUMOR NECROSIS FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CLOSTRIDIUM BUTYRICUM; COLD STRESS; CONTROLLED STUDY; ENZYME ACTIVATION; ERYTHROCYTE; EXPERIMENTAL GASTRIC ULCER; HISTOPATHOLOGY; LYMPHOCYTIC INFILTRATION; MALE; MOUSE; NEUTROPHIL CHEMOTAXIS; NONHUMAN; OXIDATIVE STRESS; PYLORUS LIGATION; STOMACH EPITHELIUM; STOMACH EROSION; STOMACH MUCOSA; ANIMAL; CHEMICALLY INDUCED; COLD; DISEASE MODEL; DRUG EFFECTS; EXERCISE; GASTRITIS; INSTITUTE FOR CANCER RESEARCH MOUSE; LIGATION; METABOLISM; MICROBIOLOGY; PATHOLOGY; PHYSIOLOGY; PYLORUS; STOMACH ULCER; SURGERY;

6-KETOPROSTAGLANDIN F1 ALPHA; ANIMALS; CATALASE; CLOSTRIDIUM BUTYRICUM; COLD TEMPERATURE; DISEASE MODELS, ANIMAL; ETHANOL; GASTRIC MUCOSA; GASTRITIS; INFLAMMATION MEDIATORS; INTERLEUKIN-1BETA; LEUKOTRIENE B4; LIGATION; MALE; MALONDIALDEHYDE; MICE, INBRED ICR; OMEPRAZOLE; OXIDATIVE STRESS; PROBIOTICS; PROTON PUMP INHIBITORS; PYLORUS; RESTRAINT, PHYSICAL; STOMACH ULCER; SUPEROXIDE DISMUTASE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84938118170     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v21.i27.8340     Document Type: Article

References (52)

1. Wallace JL. Prostaglandins, NSAIDs, and gastric mucosal protection: why doesn't the stomach digest itself? Physiol Rev 2008; 88: 1547-1565 [PMID: 18923189 DOI: 10.1152/physrev.00004.2008]
2. Zapata-Colindres JC, Zepeda-Gómez S, Montaño-Loza A, Vázquez-Ballesteros E, de Jesús Villalobos J, Valdovinos-Andraca F. The association of Helicobacter pylori infection and nonsteroidal anti-inflammatory drugs in peptic ulcer disease. Can J Gastroenterol 2006; 20: 277-280 [PMID: 16609757]
3. den Hollander WJ, Kuipers EJ. Current pharmacotherapy options for gastritis. Expert Opin Pharmacother 2012; 13: 2625-2636 [PMID: 23167300 DOI: 10.1517/14656566.2012.747510]
4. Armuzzi A, Cremonini F, Bartolozzi F, Canducci F, Candelli M, Ojetti V, Cammarota G, Anti M, De Lorenzo A, Pola P, Gasbarrini G, Gasbarrini A. The effect of oral administration of Lactobacillus GG on antibiotic-associated gastrointestinal side-effects during Helicobacter pylori eradication therapy. Aliment Pharmacol Ther 2001; 15: 163-169 [PMID: 11148433 DOI: 10.1046/j.1365-2036.2001.00923.x]
5. Cremonini F, Di Caro S, Covino M, Armuzzi A, Gabrielli M, Santarelli L, Nista EC, Cammarota G, Gasbarrini G, Gasbarrini A. Effect of different probiotic preparations on anti-helicobacter pylori therapy-related side effects: a parallel group, triple blind, placebo-controlled study. Am J Gastroenterol 2002; 97: 2744-2749 [PMID: 12425542 DOI: 10.1111/j.1572-0241.2002.07063.x]
6. Ogoshi K. Gastric Ulcer Relapse. Digestive Endoscopy 1994; 6: 219-223 [DOI: 10.1111/j.1443-1661.1994.tb00369.x]
7. Befrits R, Sjöstedt S, Tour R, Leijonmarck CE, Hedenborg L, Backman M. Long-term effects of eradication of Helicobacter pylori on relapse and histology in gastric ulcer patients: a twoyear follow-up study. Scand J Gastroenterol 2004; 39: 1066-1072 [PMID: 15545163 DOI: 10.1080/00365520410007872]
8. Chubineh S, Birk J. Proton pump inhibitors: the good, the bad, and the unwanted. South Med J 2012; 105: 613-618 [PMID: 23128806 DOI: 10.1097/SMJ.0b013e31826efbea]
9. Yu EW, Bauer SR, Bain PA, Bauer DC. Proton pump inhibitors and risk of fractures: a meta-analysis of 11 international studies. Am J Med 2011; 124: 519-526 [PMID: 21605729 DOI: 10.1016/j.amjmed.2011.01.007]
10. Khalili H, Huang ES, Jacobson BC, Camargo CA, Feskanich D, Chan AT. Use of proton pump inhibitors and risk of hip fracture in relation to dietary and lifestyle factors: a prospective cohort study. BMJ 2012; 344: e372 [PMID: 22294756 DOI: 10.1136/bmj.e372]
11. Darabi K. Proton-pump-inhibitor-induced hepatitis. South Med J 2005; 98: 844-845 [PMID: 16144190 DOI: 10.1097/01.smj.0000172795.75166.c1]
12. El-Matary W, Dalzell M. Omeprazole-induced hepatitis. Pediatr Emerg Care 2005; 21: 529-530 [PMID: 16096600 DOI: 10.1097/01.pec.0000173350.45648.9b]
13. Canani RB, Cirillo P, Roggero P, Romano C, Malamisura B, Terrin G, Passariello A, Manguso F, Morelli L, Guarino A. Therapy with gastric acidity inhibitors increases the risk of acute gastroenteritis and community-acquired pneumonia in children. Pediatrics 2006; 117: e817-e820 [PMID: 16651285 DOI: 10.1542/peds.2005-1655]
14. Eom CS, Jeon CY, Lim JW, Cho EG, Park SM, Lee KS. Use of acid-suppressive drugs and risk of pneumonia: a systematic review and meta-analysis. CMAJ 2011; 183: 310-319 [PMID: 21173070 DOI: 10.1503/cmaj.092129]
15. Sato R, Tanaka M. Intestinal distribution and intraluminal localization of orally administered Clostridium butyricum in rats. Microbiol Immunol 1997; 41: 665-671 [PMID: 9343816 DOI: 10.1111/j.1348-0421.1997.tb01909.x]
16. Woo TD, Oka K, Takahashi M, Hojo F, Osaki T, Hanawa T, Kurata S, Yonezawa H, Kamiya S. Inhibition of the cytotoxic effect of Clostridium difficile in vitro by Clostridium butyricum MIYAIRI 588 strain. J Med Microbiol 2011; 60: 1617-1625 [PMID: 21700738 DOI: 10.1099/jmm.0.033423-0]
17. Takahashi M, Taguchi H, Yamaguchi H, Osaki T, Kamiya S. Studies of the effect of Clostridium butyricum on Helicobacter pylori in several test models including gnotobiotic mice. J Med Microbiol 2000; 49: 635-642 [PMID: 10882089]
18. Swarnakar S, Mishra A, Ganguly K, Sharma AV. Matrix metallo-proteinase-9 activity and expression is reduced by melatonin during prevention of ethanol-induced gastric ulcer in mice. J Pineal Res 2007; 43: 56-64 [PMID: 17614836 DOI: 10.1111/j.1600-079X.2007.00443.x]
19. Sutanto W, de Kloet ER. The use of various animal models in the study of stress and stress-related phenomena. Lab Anim 1994; 28: 293-306 [PMID: 7830368 DOI: 10.1258/002367794780745092]
20. Diniz LR, Vieira CF, Santos EC, Lima GC, Aragão KK, Vasconcelos RP, Araújo PC, Vasconcelos Yde A, Oliveira AC, Oliveira HD, Portella VG, Coelho-de-Souza AN. Gastroprotective effects of the essential oil of Hyptis crenata Pohl ex Benth. on gastric ulcer models. J Ethnopharmacol 2013; 149: 694-700 [PMID: 23920251 DOI: 10.1016/j.jep.2013.07.026]
21. Misra HP, Fridovich I. The role of superoxide anion in the autoxidation of epinephrine and a simple assay for superoxide dismutase. J Biol Chem 1972; 247: 3170-3175 [PMID: 4623845]
22. Aebi H. Catalase in vitro. Methods Enzymol 1984; 105: 121-126 [PMID: 6727660 DOI: 10.1016/S0076-6879(84)05016-3]
23. Ohkawa H, Ohishi N, Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 1979; 95: 351-358 [PMID: 36810 DOI: 10.1016/0003-2697(79)90738-3]
24. Graziani G, D'Argenio G, Tuccillo C, Loguercio C, Ritieni A, Morisco F, Del Vecchio Blanco C, Fogliano V, Romano M. Apple polyphenol extracts prevent damage to human gastric epithelial cells in vitro and to rat gastric mucosa in vivo. Gut 2005; 54: 193-200 [PMID: 15647180 DOI: 10.1136/gut.2004.046292]
25. Zhang HQ, Ding TT, Zhao JS, Yang X, Zhang HX, Zhang JJ, Cui YL. Therapeutic effects of Clostridium butyricum on experimental colitis induced by oxazolone in rats. World J Gastroenterol 2009; 15: 1821-1828 [PMID: 19370778 DOI: 10.3748/wjg.15.1821]
26. Imase K, Takahashi M, Tanaka A, Tokunaga K, Sugano H, Tanaka M, Ishida H, Kamiya S, Takahashi S. Efficacy of Clostridium butyricum preparation concomitantly with Helicobacter pylori eradication therapy in relation to changes in the intestinal microbiota. Microbiol Immunol 2008; 52: 156-161 [PMID: 18402597 DOI: 10.1111/j.1348-0421.2008.00026.x]
27. Al Batran R, Al-Bayaty F, Jamil Al-Obaidi MM, Abdualkader AM, Hadi HA, Ali HM, Abdulla MA. In vivo antioxidant and antiulcer activity of Parkia speciosa ethanolic leaf extract against ethanol-induced gastric ulcer in rats. PLoS One 2013; 8: e64751 [PMID: 23724090 DOI: 10.1371/journal.pone.0064751]
28. Ahmad A, Husain A, Mujeeb M, Khan SA, Najmi AK, Siddique NA, Damanhouri ZA, Anwar F. A review on therapeutic potential of Nigella sativa: A miracle herb. Asian Pac J Trop Biomed 2013; 3: 337-352 [PMID: 23646296 DOI: 10.1016/S2221-1691(13)60075-1]
29. Gyires K. Neuropeptides and gastric mucosal homeostasis. Curr Top Med Chem 2004; 4: 63-73 [DOI: 10.2174/1568026043451609]
30. Tariq M, Ageel AM. Gastric antiulcer and cytoprotective effects of dipyridamole in rats. J Pharmacol Exp Ther 1990; 253: 944-949 [PMID: 2359030]
31. Konturek SJ, Piastucki I, Brzozowski T, Radecki T, Dembińska-Kieć A, Zmuda A, Gryglewski R. Role of prostaglandins in the formation of aspirin-induced gastric ulcers. Gastroenterology 1981; 80: 4-9 [PMID: 7450410]
32. Kapui Z, Boér K, Rózsa I, Blaskó G, Hermecz I. Investigations of indomethacin-induced gastric ulcer in rats. Arzneimittelforschung 1993; 43: 767-771 [PMID: 8369011]
33. Abdel Salam OM, Mózsik G, Szolcsányi J. Studies on the effect of intragastric capsaicin on gastric ulcer and on the prostacyclin-induced cytoprotection in rats. Pharmacol Res 1995; 32: 209-215 [PMID: 8866836 DOI: 10.1016/S1043-6618(05)80024-6]
34. Materia A, Jaffe BM, Money SR, Rossi P, De Marco M, Basso N. Prostaglandins in commercial milk preparations. Their effect in the prevention of stress-induced gastric ulcer. Arch Surg 1984; 119: 290-292 [PMID: 6696622]
35. Schildknecht S, Bachschmid M, Baumann A, Ullrich V. COX-2 inhibitors selectively block prostacyclin synthesis in endotoxin-exposed vascular smooth muscle cells. FASEB J 2004; 18: 757-759 [PMID: 14977876 DOI: 10.1096/fj.03-0609fje]
36. Poggi A, Niewiarowski S, Stewart GJ, Sobel E, Smith JB. Human platelet secreted proteins and prostacyclin production by bovine aortic endothelial cells. Proc Soc Exp Biol Med 1983; 172: 543-550 [PMID: 6221344 DOI: 10.3181/00379727-172-41600]
37. Qadis AQ, Goya S, Yatsu M, Kimura A, Ichijo T, Sato S. Immune-stimulatory effects of a bacteria-based probiotic on peripheral leukocyte subpopulations and cytokine mRNA expression levels in scouring holstein calves. J Vet Med Sci 2014; 76: 677-684 [PMID: 24451928 DOI: 10.1292/jvms.13-0370]
38. Scheppach W, Weiler F. The butyrate story: old wine in new bottles? Curr Opin Clin Nutr Metab Care 2004; 7: 563-567 [PMID: 15295277 DOI: 10.1097/00075197-200409000-00009]
39. Hamer HM, Jonkers D, Venema K, Vanhoutvin S, Troost FJ, Brummer RJ. Review article: the role of butyrate on colonic function. Aliment Pharmacol Ther 2008; 27: 104-119 [PMID: 17973645 DOI: 10.1111/j.1365-2036.2007.03562.x]
40. Hallert C, Björck I, Nyman M, Pousette A, Grännö C, Svensson H. Increasing fecal butyrate in ulcerative colitis patients by diet: controlled pilot study. Inflamm Bowel Dis 2003; 9: 116-121 [PMID: 12769445 DOI: 10.1097/00054725-200303000-00005]
41. Scheppach W, Sommer H, Kirchner T, Paganelli GM, Bartram P, Christl S, Richter F, Dusel G, Kasper H. Effect of butyrate enemas on the colonic mucosa in distal ulcerative colitis. Gastroenterology 1992; 103: 51-56 [PMID: 1612357]
42. Vernia P, Cittadini M, Caprilli R, Torsoli A. Topical treatment of refractory distal ulcerative colitis with 5-ASA and sodium butyrate. Dig Dis Sci 1995; 40: 305-307 [PMID: 7851194 DOI: 10.1007/BF02065414]
43. Russo I, Luciani A, De Cicco P, Troncone E, Ciacci C. Butyrate attenuates lipopolysaccharide-induced inflammation in intestinal cells and Crohn's mucosa through modulation of antioxidant defense machinery. PLoS One 2012; 7: e32841 [PMID: 22412931 DOI: 10.1371/journal.pone.0032841]
44. Kovarik JJ, Hölzl MA, Hofer J, Waidhofer-Söllner P, Sobanov Y, Koeffel R, Saemann MD, Mechtcheriakova D, Zlabinger GJ. Eicosanoid modulation by the short-chain fatty acid n-butyrate in human monocytes. Immunology 2013; 139: 395-405 [PMID: 23398566 DOI: 10.1111/imm.12089]
45. Iida T, Kawato T, Tanaka H, Tanabe N, Nakai K, Zhao N, Suzuki N, Ochiai K, Maeno M. Sodium butyrate induces the production of cyclooxygenases and prostaglandin E2 in ROS 17/2.8 osteoblastic cells. Arch Oral Biol 2011; 56: 678-686 [PMID: 21281931 DOI: 10.1016/j.archoralbio.2010.12.013]
46. Jahns F, Wilhelm A, Jablonowski N, Mothes H, Radeva M, Wölfert A, Greulich KO, Glei M. Butyrate suppresses mRNA increase of osteopontin and cyclooxygenase-2 in human colon tumor tissue. Carcinogenesis 2011; 32: 913-920 [PMID: 21459756 DOI: 10.1093/carcin/bgr061]
47. Ferreira AF, Ortigueira J, Alves L, Gouveia L, Moura P, Silva C. Biohydrogen production from microalgal biomass: energy requirement, CO2 emissions and scale-up scenarios. Bioresour Technol 2013; 144: 156-164 [PMID: 23867534 DOI: 10.1016/j.biortech.2013.06.079]
48. Jo JH, Lee DS, Park D, Park JM. Biological hydrogen production by immobilized cells of Clostridium tyrobutyricum JM1 isolated from a food waste treatment process. Bioresour Technol 2008; 99: 6666-6672 [PMID: 18248983 DOI: 10.1016/j.biortech.2007.11.067]
49. Sun YQ, Xiu ZL, Li XH, Zhang DJ. Stoichiometric analysis of biological hydrogen production by fermentative bacteria. Int J Hydrogen Energy 2006; 31: 539-549 [DOI: 10.1016/j.ijhydene.2005.03.013]
50. Cardinal JS, Zhan J, Wang Y, Sugimoto R, Tsung A, McCurry KR, Billiar TR, Nakao A. Oral hydrogen water prevents chronic allograft nephropathy in rats. Kidney Int 2010; 77: 101-109 [PMID: 19907413 DOI: 10.1038/ki.2009.421]
51. Buchholz BM, Kaczorowski DJ, Sugimoto R, Yang R, Wang Y, Billiar TR, McCurry KR, Bauer AJ, Nakao A. Hydrogen inhalation ameliorates oxidative stress in transplantation induced intestinal graft injury. Am J Transplant 2008; 8: 2015-2024 [PMID: 18727697 DOI: 10.1111/j.1600-6143.2008.02359.x]
52. Liu X, Chen Z, Mao N, Xie Y. The protective of hydrogen on stress-induced gastric ulceration. Int Immunopharmacol 2012; 13: 197-203 [PMID: 22543062 DOI: 10.1016/j.intimp.2012.04.004]